ULRRmetadata only
Targeted therapy in pancreatic ductal adenocarcinoma: current advances and challenges
pancreatic ductal adenocarcinoma, pdac, targeted therapy, precision oncology, kras, kras inhibitors, molecular profiling, parp inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 667087
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.